Interested in how your next-generation biotherapeutics can be formulated as stable dry powders requiring no cryogenic freezing or delicate handling?
Meet Ziccum CEO Ann Gidner, COO Xavier Turon and Scientific Director Fabrice Rose to hear about our latest impressive mRNA data and how our unique drying and formulation technology solves key stability issues and enables new delivery options.
Book a meeting here: https://ziccum.com/about-us/contact/